The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target is human LEMD2 (UniProt Q8NC56), also referred to in the literature as LEM2 / LEM domain-containing protein 2, an integral inner nuclear membrane (INM) protein with a LEM domain and a C-terminal winged-helix (WH)/MAN1-like (MSC) domain. Multiple retrieved sources explicitly describe LEMD2 as an INM protein and describe the LEM-domain → BAF binding and the WH/MSC → CHMP7/ESCRT-III interaction axis that matches the UniProt domain expectations. (caravia2022lossoffunction pages 1-2, johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 22-27)
LEM-domain proteins (LAP2–emerin–MAN1 family) are nuclear envelope-associated factors, typically INM localized, that connect chromatin and the nuclear lamina to nuclear-envelope structure and signaling. A defining feature is the LEM domain, described as a ~40 amino-acid bi-helical motif that binds Barrier-to-Autointegration Factor (BAF), a chromatin-associated protein. (nair2025nuclearenvelopeand pages 8-10)
LEMD2 is described as a ubiquitously expressed INM protein with a conserved N-terminal LEM domain and two transmembrane segments, localizing at the nuclear periphery. Its LEM domain enables association with DNA-associated proteins including lamins and BAF, supporting a chromatin–nuclear envelope tethering function. (caravia2022lossoffunction pages 1-2)
The ESCRT-III machinery is a membrane-remodeling system whose controlled polymerization can seal small membrane discontinuities. In nuclear-envelope maintenance, CHMP7 together with INM LEMD2 is implicated in sealing small nuclear-envelope holes, whereas repair of larger ruptures can depend more strongly on BAF-mediated mechanisms. (keeley2024nuclearanddegradative pages 3-4)
Mechanistically, LEM2/LEMD2 can recruit/activate CHMP7 via a C-terminal WH/MSC domain; CHMP7 then nucleates downstream ESCRT-III assembly for membrane sealing. (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 22-27)
LEMD2 is an integral inner nuclear membrane protein at the nuclear periphery. (caravia2022lossoffunction pages 1-2)
A structured domain/function mapping is provided below.
| Domain/region (approx. position) | Key binding partners | Cellular process/function | Key evidence (paper, year, DOI/URL) | Notes |
|---|---|---|---|---|
| N-terminal LEM domain (~40 aa motif; pathogenic p.L13R falls within this region) | BAF; lamins/chromatin-associated proteins | Tethers chromatin/heterochromatin to the inner nuclear membrane (INM); contributes to nuclear envelope (NE) integrity, chromatin stabilization, and post-mitotic NE reformation | Caravia et al., 2022, J Clin Invest, https://doi.org/10.1172/jci158897; Nair et al., 2025, Nucleus, https://doi.org/10.1080/19491034.2024.2449520 (caravia2022lossoffunction pages 1-2, nair2025nuclearenvelopeand pages 8-10) | LEM domain is described as a ~40 aa bihelical BAF-binding motif in LEM-family proteins; p.L13R reduces function and is associated with cardiomyopathy phenotypes (caravia2022lossoffunction pages 1-2, nair2025nuclearenvelopeand pages 8-10, lipov2023exploringthecomplex pages 3-4). |
| N-terminal region / LEM-domain-containing chromatin-targeting module (NTD; includes LEM domain) | BAF-coated chromatin | Targets LEMD2/LEM2 to anaphase chromatin and reforming NE; helps establish early nucleocytoplasmic compartmentalization | Johnson/von Appen, 2020, mechanistic LEM2 study (DOI not available in retrieved text); Keeley & Coyne, 2024, Nucleus, https://doi.org/10.1080/19491034.2024.2349085 (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 22-27, keeley2024nuclearanddegradative pages 3-4) | In mechanistic models, BAF–LEM engagement positions LEM2 at NE holes/fenestrations before ESCRT-III recruitment; 2024 review notes CHMP7/LEMD2 mainly seal small holes, while larger ruptures rely more on BAF-mediated mechanisms (johnson2020discoveringhowinner pages 13-16, keeley2024nuclearanddegradative pages 3-4). |
| Low-complexity domain (LCD) / phase-separating region (approx. aa 43–202; NTD aa 1–208 in LEM2 study) | Microtubules; chromatin-proximal membrane environment | Promotes local condensation/phase separation at spindle-associated membrane gaps during mitotic NE reformation; helps spatially organize membrane sealing machinery | Johnson/von Appen, 2020, mechanistic LEM2 study (DOI not available in retrieved text); Borah et al., 2022, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2022.989217 (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 35-39, borah2022thelemescrttoolkit pages 1-3) | Undergoes liquid-like phase separation; contains a microtubule-targeting/basic subregion; phosphomimetic changes block condensation, implying cell-cycle regulation (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 35-39). |
| Proline/arginine-rich microtubule-binding segment near first transmembrane helix (exact aa not fully resolved in retrieved evidence) | Spindle microtubules | Couples NE reformation to spindle disassembly/clearance; concentrates LEM2 at microtubule-occupied fenestrations | Johnson/von Appen, 2020, mechanistic LEM2 study (DOI not available in retrieved text) (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 35-39) | Supports a model in which LEMD2 bridges membranes, chromatin, and spindle microtubules to prevent persistent NE openings and genome damage (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 35-39). |
| Two transmembrane segments / membrane-embedded core | INM membrane environment; nuclear lamina-associated network | Anchors LEMD2 as an integral INM protein, enabling it to act as a chromatin–lamina tether and compartmentalization sensor at NE ruptures | Caravia et al., 2022, J Clin Invest, https://doi.org/10.1172/jci158897; Nair et al., 2025, Nucleus, https://doi.org/10.1080/19491034.2024.2449520; Borah et al., 2022, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2022.989217 (caravia2022lossoffunction pages 1-2, nair2025nuclearenvelopeand pages 8-10, borah2022thelemescrttoolkit pages 3-4) | Caravia explicitly describes LEMD2 as an INM protein with two transmembrane segments; family reviews place LEMD2 among INM LEM proteins that cooperate with lamins and ESCRT pathways (caravia2022lossoffunction pages 1-2, nair2025nuclearenvelopeand pages 8-10). |
| C-terminal winged-helix (WH) / MSC / MAN1-like domain (AA ~395–503 in LEM2 study) | CHMP7 directly; downstream ESCRT-III factors indirectly (e.g., IST1) | Recruits and activates CHMP7; nucleates ESCRT-III assembly for NE sealing/reformation and rupture repair | Johnson/von Appen, 2020, mechanistic LEM2 study (DOI not available in retrieved text); Keeley & Coyne, 2024, Nucleus, https://doi.org/10.1080/19491034.2024.2349085 (johnson2020discoveringhowinner pages 22-27, johnson2020discoveringhowinner pages 13-16, keeley2024nuclearanddegradative pages 3-4) | Direct CHMP7-binding interface; relieves CHMP7 autoinhibition and induces polymerization; central to sealing small NE holes (<100 nm) per 2024 review (johnson2020discoveringhowinner pages 22-27, keeley2024nuclearanddegradative pages 3-4). |
| LEMD2–CHMP7 functional module at NE ruptures/interphase repair sites (multi-domain emergent activity rather than single motif) | CHMP7, ESCRT-III machinery, BAF-assisted rupture context | Acts as a compartmentalization sensor that initiates ESCRT-III-dependent membrane repair at exposed chromatin/ruptures | Borah et al., 2022, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2022.989217; Keeley & Coyne, 2024, Nucleus, https://doi.org/10.1080/19491034.2024.2349085 (borah2022thelemescrttoolkit pages 3-4, keeley2024nuclearanddegradative pages 3-4) | Reviews synthesize LEMD2 as part of the conserved “LEM-ESCRT toolkit”; exposure of LEM proteins to cytosol after rupture activates/recruits CHMP7 and downstream ESCRT-III (borah2022thelemescrttoolkit pages 3-4, keeley2024nuclearanddegradative pages 3-4). |
| Full-length LEMD2/LEM2 as chromatin–lamina–ESCRT integrator | BAF, lamins, CHMP7, microtubules | Maintains genome stability by integrating chromatin tethering, lamina association, membrane remodeling, and NE repair/reformation | Caravia et al., 2022, J Clin Invest, https://doi.org/10.1172/jci158897; Johnson/von Appen, 2020; Nair et al., 2025, Nucleus, https://doi.org/10.1080/19491034.2024.2449520; Borah et al., 2022, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2022.989217; Keeley & Coyne, 2024, Nucleus, https://doi.org/10.1080/19491034.2024.2349085 (caravia2022lossoffunction pages 1-2, johnson2020discoveringhowinner pages 13-16, nair2025nuclearenvelopeand pages 8-10, borah2022thelemescrttoolkit pages 3-4, keeley2024nuclearanddegradative pages 3-4) | Loss of function causes NE deformation, DNA damage, p53 activation, apoptosis, and cardiomyopathy in vivo; this broader phenotype is consistent with failure of both structural tethering and ESCRT-coupled repair functions (caravia2022lossoffunction pages 1-2, keeley2024nuclearanddegradative pages 3-4). |
Table: This table maps the major structural regions of human LEMD2/LEM2 to their known binding partners and molecular functions at the inner nuclear membrane. It is useful for functional annotation because it links UniProt-style domain architecture to experimentally supported roles in chromatin tethering, microtubule-associated nuclear envelope reformation, and CHMP7/ESCRT-III-mediated repair.
Mitotic nuclear envelope reformation (open mitosis): Mechanistic work on LEM2 (ortholog of human LEMD2) describes it as a two-pass INM protein that coordinates ESCRT-mediated sealing during mitotic exit. The LEM domain binds BAF to target chromatin; a low-complexity region can phase-separate, and a microtubule-binding region focuses LEM2 at spindle-associated fenestrations. The C-terminal WH/MSC domain binds and activates CHMP7, promoting CHMP7 polymerization and recruitment of downstream ESCRT-III factors for NE sealing and early compartmentalization. (johnson2020discoveringhowinner pages 13-16, johnson2020discoveringhowinner pages 22-27)
Interphase rupture repair: Reviews synthesize a conserved “LEM–ESCRT toolkit” where exposure of LEM proteins at ruptures recruits CHMP7 and downstream ESCRT-III machinery, contributing to NE repair and maintenance. (borah2022thelemescrttoolkit pages 3-4, keeley2024nuclearanddegradative pages 3-4)
A 2023 study in Journal of Cell Science (C. elegans) provides primary evidence that LEM-2’s WH domain activates CHMP-7 to support ESCRT-III polymerization and NE closure, and that CHMP-7 becomes critical when BAF–LEM-mediated closure is compromised—supporting a redundancy/fallback model. While not human, it is explicitly framed in terms of homology (LEM-2 ↔ human LEMD2; CHMP-7 ↔ human CHMP7) and supports conserved mechanistic logic used in human models. (barger2023nuclearenvelopeassembly pages 12-14)
Publication date/URL: Nov 2023; https://doi.org/10.1242/jcs.261385 (barger2023nuclearenvelopeassembly pages 12-14)
A 2024 Science paper reports a pathological axis in which mitochondrial reactive oxygen species (ROS) promote CHMP7 cysteine oxidation, CHMP7 oligomerization, and enhanced binding to LEMD2, while disrupting CHMP7 interactions with canonical ESCRT-III partners. This shift is associated with micronuclear envelope collapse, chromosome shattering, and inflammation, and occurs under hypoxic conditions—connecting tumor microenvironment stress to aberrant engagement of the LEMD2–CHMP7 module. (bona2024micronuclearcollapsefrom pages 1-3)
Publication date/URL: Aug 2024; https://doi.org/10.1126/science.adj8691 (bona2024micronuclearcollapsefrom pages 1-3)
A 2024 Frontiers in Cell and Developmental Biology methods paper introduces a deterministic rupture/live-imaging pipeline and states that CHMP7–LEMD2 binding is the fundamental step enabling ESCRT-III recruitment to rupture sites, illustrating direct real-world experimental implementation for measuring recruitment dynamics at primary nuclei and micronuclei. (bona2024anewmicroscopy pages 1-2)
Publication date/URL: Sep 2024; https://doi.org/10.3389/fcell.2024.1475095 (bona2024anewmicroscopy pages 1-2)
A 2024 review (Nucleus) synthesizes that CHMP7/LEMD2 are involved in sealing small (<100 nm) nuclear-envelope holes, whereas BAF is emphasized for larger ruptures; it also emphasizes that nuclear ESCRT requirements may differ across cell types (e.g., neurons vs immortalized lines), highlighting an open problem in translating cell biology to disease contexts. (keeley2024nuclearanddegradative pages 3-4)
Publication date/URL: May 2024; https://doi.org/10.1080/19491034.2024.2349085 (keeley2024nuclearanddegradative pages 3-4)
A 2022 Journal of Clinical Investigation study created a knock-in mouse carrying the human disease allele c.T38>G (p.L13R) and showed severe dilated cardiomyopathy and fibrosis. Importantly, cardiomyocyte-specific AAV-mediated Lemd2 gene therapy rescued cardiac function in KI/KI mice, supporting a direct therapeutic concept for LEMD2-related cardiomyopathy (preclinical). (caravia2022lossoffunction pages 1-2, caravia2022lossoffunction pages 9-11)
Publication date/URL: Nov 2022; https://doi.org/10.1172/jci158897 (caravia2022lossoffunction pages 1-2)
A 2024 study in triple-negative breast cancer (TNBC) contexts reported that siRNA depletion of Lem-D family proteins (including LEMD2) in TNBC cell lines induced aberrant nuclear morphology, reduced proliferation, and cell death, with minimal effects in non-cancerous breast cells—supporting a hypothesis that INM LEM proteins may represent context-dependent vulnerabilities. (rose2024theexpressionand pages 1-2)
Publication date/URL: Apr 2024; https://doi.org/10.3389/fonc.2024.1222698 (rose2024theexpressionand pages 1-2)
The 2024 microscopy pipeline provides a standardized assay framework to study recruitment of LEMD2 and CHMP7 at ruptures (primary nuclei and micronuclei), enabling broader adoption of mechanistic nuclear-envelope repair measurements. (bona2024anewmicroscopy pages 1-2)
An emerging consensus is that LEMD2–CHMP7–ESCRT-III is well suited to seal small nuclear-envelope holes, while BAF-driven responses can dominate in large ruptures—implying parallel and partly redundant repair routes. This helps interpret why perturbing one component yields context-specific phenotypes across cell types and model systems. (keeley2024nuclearanddegradative pages 3-4, barger2023nuclearenvelopeassembly pages 12-14)
Mechanistic cardiomyopathy models support a view that LEMD2 protects mechanically stressed post-mitotic cells (cardiomyocytes) by maintaining nuclear-envelope integrity and genome stability; failure leads to DNA damage, p53 activation, apoptosis, fibrosis, and arrhythmia susceptibility. (caravia2022lossoffunction pages 1-2, caravia2022lossoffunction pages 9-11, ravera2025cardiovascularinvolvementin pages 8-9)
The 2024 Science study suggests that the LEMD2–CHMP7 module can become pathological under oxidative stress/hypoxia by driving micronuclear collapse; thus, therapeutic manipulation of this axis would need to consider the trade-off between facilitating repair and avoiding deleterious hyperactivation/mislocalization. (bona2024micronuclearcollapsefrom pages 1-3)
A 2023 cardiomyopathy genetics synthesis reports for LEMD2: 2 families and 11 biallelic cases, with exome evidence from two large pedigrees and an estimated Max LOD = 7.3. (lipov2023exploringthecomplex pages 3-4)
Publication date/URL: Oct 2023; https://doi.org/10.1038/s44161-023-00346-3 (lipov2023exploringthecomplex pages 3-4)
In the KI/KI cardiomyopathy model, AAV9-Lemd2 was delivered at 5 × 10^13 vg/kg (P4), with echocardiography at 2 months. Sample sizes included WT n=7, KI/KI n=10, and KI/KI + AAV9-Lemd2 n=4. Lemd2 mRNA was increased >10-fold after AAV, with protein restoration near WT. (caravia2022lossoffunction pages 9-11)
Cardiomyocyte-specific knockout had median survival of 2 days (caravia2022lossoffunction pages 9-11). An additional excerpt reports 50% mortality by postnatal day 2 and a survival analysis comparing controls (n=19) and cKO (n=23) with ****P<0.0001. (caravia2022lossoffunction pages 7-9, caravia2022lossoffunction pages 6-7)
A narrative review cites a homozygous Lemd2 p.L13R knock-in model with Lemd2 mRNA reduced to 65%, reduced protein levels, and conduction abnormalities (PR/QRS prolongation) at 6 months, preceding pronounced LV dilation at 9 months. (ravera2025cardiovascularinvolvementin pages 8-9)
A 2024 review states CHMP7/LEMD2 seal small NE holes such as <100 nm. (keeley2024nuclearanddegradative pages 3-4)
Foundational mechanistic measurements in LEM2/CHMP7 polymerization report WH-induced CHMP7 polymers with variable inner diameters ~50–100 nm. (johnson2020discoveringhowinner pages 22-27)
A schematic from the 2024 Science study illustrates the ROS-driven CHMP7 oligomerization and aberrant binding to LEMD2 leading to micronuclear collapse. (bona2024micronuclearcollapsefrom media c1457801, bona2024micronuclearcollapsefrom pages 1-3)
References
(caravia2022lossoffunction pages 1-2): Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, and Eric N. Olson. Loss of function of the nuclear envelope protein lemd2 causes dna damage–dependent cardiomyopathy. The Journal of Clinical Investigation, Nov 2022. URL: https://doi.org/10.1172/jci158897, doi:10.1172/jci158897. This article has 23 citations.
(johnson2020discoveringhowinner pages 13-16): IE Johnson. Discovering how inner nuclear membrane protein, lem2, orchestrates timely nuclear envelope reformation during open mitosis. Unknown journal, 2020.
(johnson2020discoveringhowinner pages 22-27): IE Johnson. Discovering how inner nuclear membrane protein, lem2, orchestrates timely nuclear envelope reformation during open mitosis. Unknown journal, 2020.
(nair2025nuclearenvelopeand pages 8-10): Anjitha Nair, Jayati Khanna, Jashan Kler, Rohith Ragesh, and Kundan Sengupta. Nuclear envelope and chromatin choreography direct cellular differentiation. Nucleus, Feb 2025. URL: https://doi.org/10.1080/19491034.2024.2449520, doi:10.1080/19491034.2024.2449520. This article has 4 citations and is from a peer-reviewed journal.
(keeley2024nuclearanddegradative pages 3-4): Olivia Keeley and Alyssa N. Coyne. Nuclear and degradative functions of the escrt-iii pathway: implications for neurodegenerative disease. Nucleus, May 2024. URL: https://doi.org/10.1080/19491034.2024.2349085, doi:10.1080/19491034.2024.2349085. This article has 16 citations and is from a peer-reviewed journal.
(lipov2023exploringthecomplex pages 3-4): Alex Lipov, Sean J. Jurgens, Francesco Mazzarotto, Mona Allouba, James P. Pirruccello, Yasmine Aguib, Massimo Gennarelli, Magdi H. Yacoub, Patrick T. Ellinor, Connie R. Bezzina, and Roddy Walsh. Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies. Nature Cardiovascular Research, 2:1078-1094, Oct 2023. URL: https://doi.org/10.1038/s44161-023-00346-3, doi:10.1038/s44161-023-00346-3. This article has 39 citations and is from a peer-reviewed journal.
(johnson2020discoveringhowinner pages 35-39): IE Johnson. Discovering how inner nuclear membrane protein, lem2, orchestrates timely nuclear envelope reformation during open mitosis. Unknown journal, 2020.
(borah2022thelemescrttoolkit pages 1-3): Sapan Borah, Karthigeyan Dhanasekaran, and Santosh Kumar. The lem-escrt toolkit: repair and maintenance of the nucleus. Frontiers in Cell and Developmental Biology, Sep 2022. URL: https://doi.org/10.3389/fcell.2022.989217, doi:10.3389/fcell.2022.989217. This article has 13 citations.
(borah2022thelemescrttoolkit pages 3-4): Sapan Borah, Karthigeyan Dhanasekaran, and Santosh Kumar. The lem-escrt toolkit: repair and maintenance of the nucleus. Frontiers in Cell and Developmental Biology, Sep 2022. URL: https://doi.org/10.3389/fcell.2022.989217, doi:10.3389/fcell.2022.989217. This article has 13 citations.
(barger2023nuclearenvelopeassembly pages 12-14): Sarah R. Barger, Lauren Penfield, and Shirin Bahmanyar. Nuclear envelope assembly relies on chmp-7 in the absence of baf–lem-mediated hole closure. Journal of Cell Science, Nov 2023. URL: https://doi.org/10.1242/jcs.261385, doi:10.1242/jcs.261385. This article has 10 citations and is from a domain leading peer-reviewed journal.
(bona2024micronuclearcollapsefrom pages 1-3): Melody Di Bona, Yanyang Chen, Albert S. Agustinus, Alice Mazzagatti, Mercedes A. Duran, Matthew Deyell, Daniel Bronder, James Hickling, Christy Hong, Lorenzo Scipioni, Giulia Tedeschi, Sara Martin, Jun Li, Aušrinė Ruzgaitė, Nadeem Riaz, Parin Shah, Edridge K. D’Souza, D. Zack Brodtman, Simone Sidoli, Bill Diplas, Manisha Jalan, Nancy Y. Lee, Alban Ordureau, Benjamin Izar, Ashley M. Laughney, Simon Powell, Enrico Gratton, Stefano Santaguida, John Maciejowski, Peter Ly, Thomas M. Jeitner, and Samuel F. Bakhoum. Micronuclear collapse from oxidative damage. Science, Aug 2024. URL: https://doi.org/10.1126/science.adj8691, doi:10.1126/science.adj8691. This article has 75 citations and is from a highest quality peer-reviewed journal.
(bona2024anewmicroscopy pages 1-2): Melody Di Bona and Samuel F. Bakhoum. A new microscopy pipeline for studying the initial stages of nuclear and micronuclear rupture and repair. Frontiers in Cell and Developmental Biology, Sep 2024. URL: https://doi.org/10.3389/fcell.2024.1475095, doi:10.3389/fcell.2024.1475095. This article has 1 citations.
(caravia2022lossoffunction pages 9-11): Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, and Eric N. Olson. Loss of function of the nuclear envelope protein lemd2 causes dna damage–dependent cardiomyopathy. The Journal of Clinical Investigation, Nov 2022. URL: https://doi.org/10.1172/jci158897, doi:10.1172/jci158897. This article has 23 citations.
(rose2024theexpressionand pages 1-2): Maddison Rose, Joshua T. Burgess, Chee Man Cheong, Mark N. Adams, Parastoo Shahrouzi, Kenneth J. O’Byrne, Derek J. Richard, and Emma Bolderson. The expression and role of the lem-d proteins ankle2, emerin, lemd2, and tmpo in triple-negative breast cancer cell growth. Frontiers in Oncology, Apr 2024. URL: https://doi.org/10.3389/fonc.2024.1222698, doi:10.3389/fonc.2024.1222698. This article has 1 citations.
(ravera2025cardiovascularinvolvementin pages 8-9): Francesco Ravera, Veronica Dusi, Pier Paolo Bocchino, Giulia Gobello, Giuseppe Giannino, Daniele Melis, Giulia Margherita Brach Del Prever, Filippo Angelini, Andrea Saglietto, Carla Giustetto, Guglielmo Gallone, Stefano Pidello, Margherita Cannillo, Marco Matteo Cingolani, Silvia Deaglio, Walter Grosso Marra, Gaetano Maria De Ferrari, and Claudia Raineri. Cardiovascular involvement in syne variants: a case series and narrative review. Cardiogenetics, 15:2, Jan 2025. URL: https://doi.org/10.3390/cardiogenetics15010002, doi:10.3390/cardiogenetics15010002. This article has 3 citations.
(caravia2022lossoffunction pages 7-9): Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, and Eric N. Olson. Loss of function of the nuclear envelope protein lemd2 causes dna damage–dependent cardiomyopathy. The Journal of Clinical Investigation, Nov 2022. URL: https://doi.org/10.1172/jci158897, doi:10.1172/jci158897. This article has 23 citations.
(caravia2022lossoffunction pages 6-7): Xurde M. Caravia, Andres Ramirez-Martinez, Peiheng Gan, Feng Wang, John R. McAnally, Lin Xu, Rhonda Bassel-Duby, Ning Liu, and Eric N. Olson. Loss of function of the nuclear envelope protein lemd2 causes dna damage–dependent cardiomyopathy. The Journal of Clinical Investigation, Nov 2022. URL: https://doi.org/10.1172/jci158897, doi:10.1172/jci158897. This article has 23 citations.
(bona2024micronuclearcollapsefrom media c1457801): Melody Di Bona, Yanyang Chen, Albert S. Agustinus, Alice Mazzagatti, Mercedes A. Duran, Matthew Deyell, Daniel Bronder, James Hickling, Christy Hong, Lorenzo Scipioni, Giulia Tedeschi, Sara Martin, Jun Li, Aušrinė Ruzgaitė, Nadeem Riaz, Parin Shah, Edridge K. D’Souza, D. Zack Brodtman, Simone Sidoli, Bill Diplas, Manisha Jalan, Nancy Y. Lee, Alban Ordureau, Benjamin Izar, Ashley M. Laughney, Simon Powell, Enrico Gratton, Stefano Santaguida, John Maciejowski, Peter Ly, Thomas M. Jeitner, and Samuel F. Bakhoum. Micronuclear collapse from oxidative damage. Science, Aug 2024. URL: https://doi.org/10.1126/science.adj8691, doi:10.1126/science.adj8691. This article has 75 citations and is from a highest quality peer-reviewed journal.
(barger2023nuclearenvelopeassembly pages 25-27): Sarah R. Barger, Lauren Penfield, and Shirin Bahmanyar. Nuclear envelope assembly relies on chmp-7 in the absence of baf–lem-mediated hole closure. Journal of Cell Science, Nov 2023. URL: https://doi.org/10.1242/jcs.261385, doi:10.1242/jcs.261385. This article has 10 citations and is from a domain leading peer-reviewed journal.